Clinical trial
TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis
NCT00001862 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00001862 |
|---|---|
| Title | TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis |
| Official title | The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Juvenile Rheumatoid Arthritis, Uveitis |
| Intervention type | Drug |
| Interventions | Enbrel |
| Enrollment | 15 |
| Start date | Feb 1, 1999 |
| Completion | Mar 1, 2003 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: